Preliminary study evaluating the pathogenesis of malignant tumors using 18F-FAPI-74 PET
Not Applicable
Recruiting
- Conditions
- Malignant tumor
- Registration Number
- JPRN-UMIN000051687
- Lead Sponsor
- Kobe City Medical Center General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1. Those who are or may be pregnant 2. Those who are with severe claustrophobia 3. Those who are considered to be inappropriate to participate in this study by the principal investigator or sub-investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ptake difference of 18F-FAPI-74 PET/CT for the organ, lesion, or pathological status
- Secondary Outcome Measures
Name Time Method 1. Difference in lesion uptake between 18F-FAPI-74 PET/CT and 18F-FDG PET/CT 2. Relationship between 18F-FAPI-74 PET/CT uptake and specific tumor markers for each malignancy 3. Optimal acquisition time of 18F-FAPI-74 PET/CT